Tecovirimat

N/A

Report date: 2025/05/12 10:12:25
NMEFirst In Class

Base Information

Drug NameTecovirimat
Drug Alias Nametecovirimat特韦利玛Tecovirimat monohydrate - SIGA Technologies替韦立马特考韦瑞 +[12
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRecombinant envelope protein inhibitors
TargetsRecombinant envelope protein
Therapy Area/IndicationsOrthopoxvirus InfectionVacciniaSmallpox +[6
Global Approved IndicationsVacciniaSmallpoxMonkeypox +[5
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2018/07/13
Country/TerritoryCanadaUnited StatesUnited Kingdom +[5
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesSiga Technologies Inc
China Registration ClassN/A

Other Information

ATC CodeJ05AX24
Related LinksWikipediaKEGG